In this presentation, ALF explored the cutting-edge advancements in noninvasive diagnostic biomarkers, highlighting the roles of MMP7 and FIInD Green for babies with biliary atresia (BA). We also looked at the latest approaches for managing care after a Kasai procedure, offering valuable insights into enhancing treatment outcomes and patient well-being.
Last updated on February 28th, 2025 at 09:55 am